Gardasil (V501)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gardasil (V501), covering 2020-05-04 to 2020-05-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Immunogenicity, Safety and Tolerability of Quadrivalent Human Papillomavirus Vaccine (V501) in Chinese Girls Aged 9-19 Years and Young Women Aged 20-26 Years (V501-213) [Phase 3]